These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6475940)

  • 1. Effect of heparin on platelet aggregation.
    Saba HI; Saba SR; Morelli GA
    Am J Hematol; 1984 Oct; 17(3):295-306. PubMed ID: 6475940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-mediated neutralization of platelet antiaggregatory activity of prostacyclin (PGI2): studies on mechanism.
    Saba SR; Saba HI
    Am J Hematol; 1985 Oct; 20(2):97-105. PubMed ID: 3898823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin-mediated inhibition of human platelet aggregation.
    Saba HI; Saba SR; Morelli G; Hartmann RC
    Thromb Res; 1984 Apr; 34(1):19-33. PubMed ID: 6328692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation following heparin and protamine administration.
    Ellison N; Edmunds LH; Colman RW
    Anesthesiology; 1978 Jan; 48(1):65-8. PubMed ID: 619707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of heparinase 1 and protamine on platelet reactivity.
    Ammar T; Fisher CF
    Anesthesiology; 1997 Jun; 86(6):1382-6. PubMed ID: 9197309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation.
    Krishnamurthi S; Westwick J; Kakkar VV
    Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An objective assessment of the interaction of heparin and its fractions with human platelets.
    Brace LD; Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):190-8. PubMed ID: 4035366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of heparin-induced potentiation of platelet aggregation.
    Yamamoto M; Watanabe K; Ando Y; Iri H; Handa H; Yoshii Y; Imai M; Sugiura K; Ikeda Y
    Thromb Res; 1982 May; 26(3):159-64. PubMed ID: 7112512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
    Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
    J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry.
    Kozek-Langenecker SA; Mohammad SF; Masaki T; Kamerath C; Cheung AK
    Anesth Analg; 2000 Apr; 90(4):808-12. PubMed ID: 10735780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A; Davì G; Novo S; Custro N; Mattina A; Gallo V
    Int Angiol; 1985; 4(3):379-82. PubMed ID: 3913716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
    Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
    Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.